Net Income Summary of NGL Fine-Chem Limited

NGL Fine-Chem Limited's latest annual net income in 2023 was 413.16 Million INR , up 101.58% from previous year.
NGL Fine-Chem Limited's latest quarterly net income in 2024 Q1 was 92.19 Million INR , down -25.04% from previous quarter.
NGL Fine-Chem Limited reported an annual net income of 204.96 Million INR in 2022, down -58.92% from previous year.
NGL Fine-Chem Limited reported an annual net income of 498.97 Million INR in 2021, down -12.03% from previous year.
NGL Fine-Chem Limited reported a quarterly net income of 104.78 Million INR for 2023 Q2, up 23.17% from previous quarter.
NGL Fine-Chem Limited reported a quarterly net income of 413.16 Million INR for 2023 FY, up 101.58% from previous quarter.

Annual Net Income Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Net Income of NGL Fine-Chem Limited (2023 - 2007)

Year	Net Income	Net Income Growth
2023	413.16 Million INR	101.58%
2022	204.96 Million INR	-58.92%
2021	498.97 Million INR	-12.03%
2020	567.19 Million INR	580.47%
2019	83.35 Million INR	-58.59%
2018	201.26 Million INR	59.83%
2017	125.92 Million INR	-11.56%
2016	142.38 Million INR	24.92%
2015	113.98 Million INR	36.83%
2014	83.3 Million INR	83.95%
2013	45.28 Million INR	55.66%
2012	29.09 Million INR	177.87%
2011	10.46 Million INR	-56.66%
2010	24.15 Million INR	-10.68%
2009	27.04 Million INR	60.69%
2008	16.83 Million INR	967.89%
2007	1.57 Million INR	0.0%

Year	Net Income	Net Income Growth
2024 Q1	92.19 Million INR	-25.04%
2023 Q2	104.78 Million INR	23.17%
2023 FY	413.16 Million INR	101.58%
2023 Q4	122.98 Million INR	22.57%
2023 Q3	100.33 Million INR	-4.24%
2023 Q1	85.06 Million INR	-5.33%
2022 FY	204.96 Million INR	-58.92%
2022 Q1	5.17 Million INR	-92.34%
2022 Q2	46.69 Million INR	801.89%
2022 Q3	64.86 Million INR	38.93%
2022 Q4	89.85 Million INR	38.52%
2021 Q1	191.25 Million INR	38.24%
2021 Q4	67.6 Million INR	-32.02%
2021 FY	498.97 Million INR	-12.03%
2021 Q3	99.45 Million INR	-28.52%
2021 Q2	139.13 Million INR	-27.25%
2020 Q1	93.87 Million INR	5683.71%
2020 Q2	158.07 Million INR	68.4%
2020 FY	567.19 Million INR	580.47%
2020 Q4	138.35 Million INR	-21.88%
2020 Q3	177.09 Million INR	12.03%
2019 Q2	23.46 Million INR	-54.85%
2019 FY	83.35 Million INR	-58.59%
2019 Q3	11.27 Million INR	-51.95%
2019 Q1	51.96 Million INR	-23.72%
2019 Q4	-1.68 Million INR	-114.91%
2018 Q2	44.18 Million INR	-8.35%
2018 Q1	48.21 Million INR	56.88%
2018 Q3	40.71 Million INR	-7.86%
2018 Q4	68.11 Million INR	67.31%
2018 FY	201.26 Million INR	59.83%
2017 Q3	25.8 Million INR	-25.14%
2017 Q1	16 Million INR	-53.66%
2017 FY	125.92 Million INR	-11.56%
2017 Q4	30.73 Million INR	19.12%
2017 Q2	34.46 Million INR	115.34%
2016 Q1	39.32 Million INR	12.49%
2016 Q2	28.7 Million INR	-27.01%
2016 FY	142.38 Million INR	24.92%
2016 Q4	34.53 Million INR	-13.07%
2016 Q3	39.73 Million INR	38.43%
2015 FY	113.98 Million INR	36.83%
2015 Q4	34.95 Million INR	26.11%
2015 Q3	27.72 Million INR	8.5%
2015 Q2	25.54 Million INR	-7.94%
2015 Q1	27.75 Million INR	-4.98%
2014 Q4	29.2 Million INR	104.09%
2014 Q3	14.31 Million INR	-37.35%
2014 Q2	22.84 Million INR	30.14%
2014 Q1	17.55 Million INR	96.63%
2014 FY	83.3 Million INR	83.95%
2013 Q1	17.29 Million INR	64.33%
2013 Q3	6.31 Million INR	-60.35%
2013 Q4	8.92 Million INR	41.38%
2013 FY	45.28 Million INR	55.66%
2013 Q2	15.92 Million INR	-7.93%
2012 Q1	9.52 Million INR	117.5%
2012 Q3	5.49 Million INR	78.23%
2012 Q2	3.08 Million INR	-67.65%
2012 FY	29.09 Million INR	177.87%
2012 Q4	10.52 Million INR	91.63%
2011 FY	10.46 Million INR	-56.66%
2011 Q4	4.37 Million INR	172.03%
2011 Q3	1.61 Million INR	0.0%
2010 FY	24.15 Million INR	-10.68%
2009 FY	27.04 Million INR	60.69%
2008 FY	16.83 Million INR	967.89%
2008 Q4	3.74 Million INR	0.0%
2007 FY	1.57 Million INR	0.0%
2007 Q4	5.77 Million INR	0.0%

Peer Net Income Comparison of NGL Fine-Chem Limited

Name	Net Income	Net Income Difference
Abbott India Limited	12.01 Billion INR	96.56%
Cipla Limited	41.21 Billion INR	98.998%
Gland Pharma Limited	7.72 Billion INR	94.651%
GlaxoSmithKline Pharmaceuticals Limited	5.89 Billion INR	92.997%
Kopran Limited	509.56 Million INR	18.917%
Marksans Pharma Limited	3.13 Billion INR	86.829%
Pfizer Limited	5.51 Billion INR	92.506%
Sanofi India Limited	6.02 Billion INR	93.147%
SMS Pharmaceuticals Limited	498.26 Million INR	17.078%
TTK Healthcare Limited	628.41 Million INR	34.253%

Global Stocks Search

NGL Fine-Chem Limited (NGLFINE.NS)

Net Income Summary of NGL Fine-Chem Limited

Annual Net Income Chart of NGL Fine-Chem Limited (2023 - 2007)

Historical Annual Net Income of NGL Fine-Chem Limited (2023 - 2007)

Peer Net Income Comparison of NGL Fine-Chem Limited